Cognitive Behavioral Therapy and Biofeedback for Chronic Headache: Effects on Pain Catastrophizing, Sleep Quality, and Disability
Abstract
To compare the effectiveness of Cognitive Behavioral Therapy (CBT), Biofeedback and their combination on pain catastrophizing, sleep quality, and headache-related disability among patients with chronic daily headache (CDH).In a randomized controlled trial conducted at a tertiary care hospital in North India, 100 patients diagnosed with CDH were randomly assigned to four groups: CBT (n = 25), Biofeedback (n = 25), Combined CBT + Biofeedback (n = 25) and Treatment-as-Usual (TAU; n = 25). Assessments were conducted at baseline, post-intervention, and at a 2-month follow-up using the Pain Catastrophizing Scale (PCS), Pittsburgh Sleep Quality Index (PSQI) and Migraine Disability Assessment Scale (MIDAS). Significant time effects were observed for all outcomes-pain catastrophizing (F = 147.39, p 2ₚ = 0.67), sleep quality (F = 92.68, p 2ₚ = 0.56), and headache-related disability (χ2 = 99.10, p < .001). Time × group interactions were also significant for PCS (p = .026) and PSQI (p = .048), indicating differential patterns of improvement across interventions. Post-hoc analyses revealed that the combined CBT + BFB group showed the greatest and most sustained improvements in pain catastrophizing and sleep quality. Headache-related disability decreased significantly in all intervention groups. CBT and Biofeedback are effective psychological interventions for managing chronic headache, with their integration producing superior and sustained outcomes. The findings highlight the utility of…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 100 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.